Two-Year Use of Exenatide Once Weekly in Type 2 Diabetes Mellitus (T2DM) Patients Taking Thiazolidinedione

被引：0
|
作者：
Trautmann, Michael
Norwood, Paul
Pintilei, Ella
Liutkus, Joanne
Haber, Harry
Boardman, Marilyn
机构：
来源：
DIABETES | 2012年 / 61卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1135-P
引用
收藏
页码：A293 / A293
页数：1
相关论文
共 50 条
  • [1] Safety of Exenatide Once Weekly in Patients with Type 2 Diabetes Treated with a Thiazolidinedione
    Norwood, Paul
    Pintilei, Ella
    Pop, Lavinia
    Liutkus, Joanne
    Choi, Suktae
    Giaconia, Joseph
    Trautman, Michael
    [J]. DIABETES, 2010, 59 : A195 - A195
  • [2] Exenatide once weekly in type 2 diabetes mellitus
    Bischoff, Lindsay A.
    Jabbour, Serge A.
    Miller, Jeffrey L.
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2011, 12 (08) : 1297 - 1303
  • [3] Safety of Exenatide Once Weekly in Patients With Type 2 Diabetes Mellitus Treated With a Thiazolidinedione Alone or in Combination With Metformin for 2 Years
    Norwood, Paul
    Liutkus, Joanne F.
    Haber, Harry
    Pintilei, Ella
    Boardman, Marilyn K.
    Trautmann, Michael E.
    [J]. CLINICAL THERAPEUTICS, 2012, 34 (10) : 2082 - 2090
  • [4] Utilisation of Once Weekly Exenatide (Bydureon®) for Type 2 Diabetes Mellitus (T2DM): Interim Results from an Observational Cohort Study in England
    Coughtrie, Abigail
    Layton, Deborah
    Qiao, Qing
    Shakir, Saad
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2016, 25 : 193 - 194
  • [5] Utilisation of a New Once Weekly Injection for Type 2 Diabetes Mellitus (T2DM): Interim Results from an Observational Cohort Study of Exenatide (Bydureon®) in England
    Osborne, Vicki
    Qayum, Naseer
    Coughtrie, Abigail
    Layton, Deborah
    Shakir, Saad A. W.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2015, 24 : 86 - 87
  • [6] EXENATIDE ONCE-WEEKLY (EQW) PHARMACOKINETICS AND HBA1C EXPOSURE RESPONSE ARE SIMILAR BETWEEN ADOLESCENT PATIENTS WITH TYPE 2 DIABETES MELLITUS (T2DM) AND ADULTS WITH T2DM.
    Edlund, H.
    Melin, J.
    Penland, R.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2022, 111 : S40 - S40
  • [7] Exenatide once weekly in type 2 diabetes
    Scheen, Andre J.
    [J]. LANCET, 2008, 372 (9645): : 1197 - 1198
  • [8] Once Weekly Dulaglutide Enhances β-Cell Function Compared to Metformin in Patients with Type 2 Diabetes (T2DM)
    Mari, Andrea
    Del Prato, Stefano
    Ludvik, Bernhard
    de la Pena, Amparo
    Shurzinske, Linda
    Pechtner, Valeria
    [J]. ENDOCRINE REVIEWS, 2014, 35 (03)
  • [9] Pathophysiological and Pharmacological Rationale for the Use of Exenatide Once Weekly in Patients with Type 2 Diabetes
    Samuel S. Grossman
    [J]. Advances in Therapy, 2014, 31 : 247 - 263
  • [10] Pathophysiological and Pharmacological Rationale for the Use of Exenatide Once Weekly in Patients with Type 2 Diabetes
    Grossman, Samuel S.
    [J]. ADVANCES IN THERAPY, 2014, 31 (03) : 247 - 263
12345